Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway
Meng Qiao(Inner Mongolia University), Antonino Passaniti(University of Maryland, Baltimore)
Cited by 144
Related Papers
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis
|Cancer Immunology Immunotherapy|2018|99
Advances on the in vivo and in vitro glycosylations of flavonoids
|Applied Microbiology and Biotechnology|2020|91
Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway
|Journal of Biological Chemistry|2009|37
Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment
|Experimental Hematology and Oncology|2024|29
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer
|Journal for ImmunoTherapy of Cancer|2022|12